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Abstract
Diffusion MRI studies consistently report group differences in white matter
between individuals diagnosed with schizophrenia and healthy controls. Neverthe-
less, the abnormalities found at the group-level are often not observed at the indi-
vidual level. Among the different approaches aiming to study white matter
abnormalities at the subject level, normative modeling analysis takes a step towards
subject-level predictions by identifying affected brain locations in individual sub-
jects based on extreme deviations from a normative range. Here, we leveraged a
large harmonized diffusion MRI dataset from 512 healthy controls and 601 individ-
uals diagnosed with schizophrenia, to study whether normative modeling can
improve subject-level predictions from a binary classifier. To this aim, individual
deviations from a normative model of standard (fractional anisotropy) and advanced
(free-water) dMRI measures, were calculated by means of age and sex-adjusted z-
scores relative to control data, in 18 white matter regions. Even though larger effect
sizes are found when testing for group differences in z-scores than are found with
raw values (p < .001), predictions based on summary z-score measures achieved
low predictive power (AUC < 0.63). Instead, we find that combining information
from the different white matter tracts, while using multiple imaging measures simul-
taneously, improves prediction performance (the best predictor achieved
AUC = 0.726). Our findings suggest that extreme deviations from a normative
model are not optimal features for prediction. However, including the complete dis-
tribution of deviations across multiple imaging measures improves prediction, and
could aid in subject-level classification.
K E YWORD S
diffusion magnetic resonance imaging, machine learning, precision medicine, schizophrenia,
white matter
1 | INTRODUCTION
Aligned with postmortem findings of anomalies in white matter (Coyle,
Balu, Puhl, & Konopaske, 2016; Friston, 1998), diffusion MRI (dMRI)
studies consistently demonstrate a disturbed white matter structural
organization in schizophrenia (Cetin-Karayumak et al., 2020; Ellison-
Wright & Bullmore, 2009; Kelly et al., 2018; Kubicki et al., 2007;
Skudlarski et al., 2013). For example, the largest, multisite case–control
analysis of dMRI measures in schizophrenia to date, Kelly et al. (2018),
observed significantly lower fractional anisotropy (FA) (Basser,
Mattiello, & LeBihan, 1994), in the schizophrenia group, in 20 of
25 white matter regions examined.
The vast majority of dMRI studies in schizophrenia apply case–
control comparisons between individuals diagnosed with schizophre-
nia and healthy controls to identify significant group-level differences
in specified white matter locations. However, group differences that
are found in a case–control comparison do not imply abnormalities in
a given individual subject (see e.g. Arbabshirani, Plis, Sui, &
Calhoun, 2017). For example, the hallmark finding of widespread FA
reductions in the schizophrenia group (Kelly et al., 2018), does not
necessarily imply that widespread FA reductions are present in every
individual diagnosed with schizophrenia, although an implicated loca-
tion may be present in a subset of individuals. This highlights the need
for alternative analysis paradigms that can better account for individ-
ual variation in pathological loci.
There are two leading analysis methods that provide subject spe-
cific inferences: The first is prediction modeling, which aims to classify
each subject into one of several groups, thereby making it more suit-
able for clinical diagnosis. The second is normative modeling, which
aims to characterize individual variations in reference to a normative
range. Unlike the case–control approach that searches for group dif-
ferences in the mean value of some feature in a specific brain location
(e.g., mean FA in one specific white matter tract), prediction
approaches search for features that maximize the separation between
the groups. Separation is usually measured by the area under the
receiver operator curve (AUC) of a particular prediction classifier. Previ-
ous studies (see e.g. Ardekani et al., 2011; Lee et al., 2018; Mikolas
et al., 2018; Rathi et al., 2010 and the references therein) have already
demonstrated that dMRI measures can serve as discriminative fea-
tures in the discrimination of individuals diagnosed with schizophrenia
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from healthy controls, but suffered from relatively small sample sizes,
which questions the generalizability of their results.
Normative modeling is an alternative paradigm, based on the
notion that different individuals could be affected by different pat-
terns of abnormality. In normative modeling, the range of variation
within the control group is modeled first, and then individual devia-
tions from this range are calculated, providing information about
potential abnormalities in each particular individual. This is different
from the case–control approach, which assumes a consistent pattern
of abnormality across individuals that belong to the same group. Devi-
ations are typically quantified using a z-score, relative to the control
group, and abnormalities are identified as those values that are out-
liers relative to the distribution of the control group, that is, having z-
scores with an absolute value larger than a threshold (Bouix
et al., 2013; Marquand et al., 2019; Marquand, Rezek, Buitelaar, &
Beckmann, 2016). The ability of the normative modeling approach to
shed light on individualized abnormality profiles was leveraged by
studies applying normative modeling on various neuroimaging
datasets, often to investigate heterogeneity of abnormalities across
subjects. Studies applying normative modeling on diffusion MRI are
available, for example, in traumatic brain injuries (Bouix et al., 2013;
Pasternak et al., 2014; Taylor, da Silva, Blamire, Wang, &
Forsyth, 2020), autism and brain development (Chamberland
et al., 2020; Dean III et al., 2017; Dimitrova et al., 2020). A few studies
have also applied normative modeling on data from subjects diag-
nosed with schizophrenia, using diffusion MRI (Lv et al., 2020; White,
Schmidt, & Karatekin, 2009) and T1-weighted MRI (Alexander-Bloch
et al., 2014; Wolfers et al., 2018, 2021). References to more studies
applying normative modeling on different datasets can be found in
Marquand et al. (2019).
The few published normative modeling studies applied on subjects
diagnosed with schizophrenia, using diffusion MRI (Lv et al., 2020;
White et al., 2009), or T1-weighted MRI (Wolfers et al., 2018, 2021),
found high interindividual differences in the locations of the implicated
brain abnormalities. In a recent study, applying normative modeling on
diffusion MRI data (Lv et al., 2020), it was further shown that the
majority of individuals with schizophrenia had at least one abnormal
location implicated, when considering FA as the modality of choice. At
the same time, however, a large number of healthy controls also
showed at least one abnormal location.
While normative modeling aims to provide useful insights at the
subject-level, previous studies did not utilize the framework to go
beyond group-level differences between the schizophrenia and con-
trol groups. In this article, we use a large sample of harmonized dMRI
data (Cetin-Karayumak et al., 2020), comprised of 512 healthy con-
trols and 601 individuals diagnosed with schizophrenia, to evaluate
the predictive power of features derived from a normative modeling
approach and compare it with the predictive power of raw dMRI
values serving as features. Here, our motivation is to improve the
characterization of the schizophrenia group as a whole by assuming
that common abnormalities (e.g., decreased FA/FAt, increased FW)
may occur in spatially distinct regions across subjects. By using the
features obtained from the normative model in a classification
scheme, we test whether these profiles provide an improved charac-
terization of the group, compared to the raw values.
We emphasize that as the diagnosis of schizophrenia relies upon
identifying several different combinations of clinical symptoms and
behavioral signs through an interview with a medical specialist, we do
not expect that combining the normative modeling approach with
classification would yield a performance that is comparable to clinical
diagnosis. Rather, our aim is to provide new information about white
matter abnormalities in schizophrenia using the combination of the
two approaches, which may be proven useful in the future design of
classification schemes for the diagnosis of schizophrenia.
Previous studies utilizing this dataset have already demonstrated
significant group-differences in FA across the life span between
healthy controls and individuals diagnosed with schizophrenia, as well
as age effects (Cetin-Karayumak et al., 2020), and sex effects in
healthy controls (Seitz et al., 2020). Here, we take a step towards
subject-level inferences by investigating the application of the norma-
tive modeling approach on this dataset. We first generate a normative
model by estimating age- and sex-adjusted z-scores from standard
(FA) and advanced (Free-water) dMRI measures in 18 white matter
regions of interest (ROIs). Then, for every subject, the predictive per-
formance of the following features is calculated and compared with
the predictive performance of the raw dMRI values: (1) z-scores
obtained by applying the normative modeling approach on FA values;
(2) summary measures for the z-score distributions (Pasternak
et al., 2014); (3) z-scores and summary measures obtained by applying
the normative modeling approach on free-water imaging derived mea-
sures (Pasternak, Sochen, Gur, Intrator, & Assaf, 2009) rather
than on FA.
2 | MATERIALS AND METHODS
2.1 | Participants, imaging acquisition, image
preprocessing and harmonization procedures
The dataset used in this study coincides with the dataset utilized in
the published work by (Cetin-Karayumak et al., 2020), which includes
601 individuals diagnosed with schizophrenia-spectrum disorder
across multiple illness stages (mean [SD] age, 31.46 [12.31] years;
380 [63.23%] male), and 512 healthy controls (mean [SD] age, 30.15
[14.26] years; 279 [54.49%] male). dMRI data were collated from
13 different sites across a number of separate studies. The single shell
dMRI data followed a standardized preprocessing protocol and were
harmonized across sites to remove site-related differences using ret-
rospective harmonization (Karayumak et al., 2019; Ning et al., 2020).
In particular, Cetin-Karayumak et al. (2020) evaluated the perfor-
mance of the harmonization procedure by using unpaired t tests to
assess between-site differences and showed that statistical differ-
ences between matched controls across sites were removed after har-
monization (see Figure S2 in Cetin-Karayumak et al., 2020). We note
that following the harmonization, site differences between subjects
diagnosed with schizophrenia are likely to occur, because of different
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distributions across sites of parameters such as age, sex, and type of
clinical populations. These differences are important to be preserved,
as they reflect true variability related to the disorder, while scanner
related differences are removed. A complete account of demo-
graphics, inclusion and exclusion criteria, acquisition protocols across
the 13 sites, preprocessing and harmonization procedures can be
found in Cetin-Karayumak et al. (2020). Following harmonization, all
data had isotropic resolution of 1.5 mm  1.5 mm  1.5 mm, with a
b-value of 1,000 s/mm2.
2.2 | White matter processing
The harmonized data were fitted using FSL's DTIFIT (Behrens
et al., 2003) to the DTI model, from which FA was derived. The data
were also fitted to the two-compartments Free-water imaging model
(including a free-water compartment and a tissue compartment) using
a regularized nonlinear fit (Pasternak et al., 2009). In this process, the
fractional volume of the free-water compartment (FW) as well as
the FA of the tissue compartment (FAt) were estimated, as previous
work suggests that these may increase sensitivity to underlying
pathologies (Lyall et al., 2018; Pasternak et al., 2012; Pasternak,
Westin, Dahlben, Bouix, & Kubicki, 2015).
To define white matter regions of interest (ROIs) we used the IIT
Human Brain probabilistic white matter fiber tract ROIs atlas v. 4.1
(Varentsova, Zhang, & Arfanakis, 2014) with a threshold of 0.25,
resulting in a total of 17 white matter fiber tract ROIs. The FA image
of each subject was registered to the FA IIT template using ANTs reg-
istration (Avants et al., 2011), and this transformation was applied to
the other diffusion measures (FAt, FW). For each tract, mean FA, FAt
and FW were computed across all voxels traversing the fiber bundle.
Since the IIT atlas v.4.1 that we used does not cover all of the white-
matter, we complemented the analysis by computing the white matter
skeleton averaged FA, FAt and FW across voxels comprising the IIT
white matter skeleton template (IIT_WM_atlas_skeletonized.nii.gz)
(Varentsova et al., 2014).
2.3 | Construction of a normative model
The normative model represents the distribution of the normative
range within each ROI in the healthy controls using the sample mean
and standard deviation. To control for confounding factors resulting
from age and sex differences, we represented the normative range in
each ROI by an age specific weighted mean, cmh, and standard devia-
tion, bσ2h , for each sex separately. To do so, we used the Nadaraya-





















  , ð1bÞ
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The procedure therefore guarantees that we select the bandwidth for
which the weighted mean cmh best reflects the normative range. The
chosen bandwidths are reported in Table S1.
2.4 | Calculation of deviation from the
normative model
The deviation of every individual diagnosed with schizophrenia from
the normative atlas, in each ROI, was captured by a z-score, calculated
using the NW estimators cmh, bσh2 (see Equations (1a) and (1b)),
z xð Þ¼ ycmh xð Þbσh xð Þ ,
where x is the subject's age and y is the subject's dMRI value (e.g., the
mean FA value over the ROI). The z-scores were truncated to the
range 10,10½ . The same procedure was also used to evaluate devia-
tion of each healthy control subject, but with a leave-one-out approach,
that is, we compared a given healthy control subject with a normative
model composed of all healthy control subjects, excluding the one being
evaluated. As a result, for each subject, and for each dMRI value (FA,
FAt, or FW), we obtained a vector with 18 z-scores (for 17 tracts +
white matter skeleton) representing deviation from the normative model.
Our approach is summarized in Figure 1, as well as in Algorithm 1.
2.5 | Group-level differences in ROI-wise values
Group comparisons of raw dMRI values (i.e., the FA, FAt and FW
values before the construction of the normative model) and z-score
values (for FA, FAt and FW) of all subjects in each ROI were
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performed using 1-tailed Welch's t tests (Welch, 1951) searching for
lower FA and FAt values and higher FW values in the schizophrenia
group. Welch's t test inherently accounts for possible unequal vari-
ance or sample size in the two compared groups, and is equivalent to
the Student's t test whenever sample size and variance in the two
compared groups are equal (Delacre, Lakens, & Leys, 2017). We also
report Cohen's d effect size (Cohen, 2013) for every hypothesis test.
To allow comparisons with subsequent tests, we also used 1-tailed
two-sample Wilcoxon ranks sum tests.
2.6 | z-score derived summary measures
To define abnormal z-scores we used the threshold of jzj > 2.999,
corresponding to p < .05 Bonferroni corrected for 18 tests (for
18 ROIs). ROIs with z-scores above 2.999 were defined as supra-nor-
mal, ROIs with z-scores below 2.999 were defined as infra-normal.
To identify if a particular ROI is implicated, for each ROI we counted
how many times it is found abnormal across the entire schizophrenia
group. To account for a possible heterogeneity in the abnormality
location in different subjects, we derived for each subject z-score
summary measures that are indifferent to the spatial location of the
abnormality. The summary measures included: fraction of abnormal
ROIs (also called “load” [Bouix et al., 2013]), z-score with the largest
absolute value (also called “severity” [Bouix et al., 2013]), average z-
score, standard-deviation of z-scores and fraction of ROIs having z-
scores in the significant range (see below for a definition of the signifi-
cant range). Since the distribution of the “load” measure is skewed
and strongly deviate from the normal distribution in both groups, we
used 1-tailed two-sample Wilcoxon rank sum tests to perform group
comparisons of all summary measures. We also report Cliff's delta
effect size (Cliff, 1993) for every hypothesis test. Cliff's delta effect
size estimates the difference between two probability scores: (1) the
probability that a value selected from one of the groups is greater
than a value selected from the other group, and (2) the probability of
the reverse case. This test is nonparametric and based on the ordinal
structure of the data, which is appropriate for data distributions that
deviate from normal.
2.7 | z-distribution
To better focus on the range of z-scores that best discriminates indi-
viduals diagnosed with schizophrenia from healthy controls, the distri-
bution of z-scores was estimated for each subject by collecting the z-
scores in all ROIs and computing the probability density function
(PDF), regularized by a normal distribution kernel, in 50 equally spaced
bins that cover the range (10,10). We then compared the PDFs
between the healthy controls and the schizophrenia groups by com-
paring the density in each bin, using a 1-tailed Welch's t test searching
for higher values in the schizophrenia group. This comparison pro-
vided a range of z-scores (referred to as the significant range) which
appear significantly more frequently in the schizophrenia group than
in the healthy controls group.
2.8 | Prediction models
We examined the diagnostic potential of the normative modeling
approach by using the z-score maps, as well as the z-score derived
measures, as inputs to a binary classifier, with the aim of classifying
individual subjects as either healthy controls or as diagnosed with
F IGURE 1 A flowchart summarizing the analysis scheme. The details are provided in the text
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schizophrenia. In comparison, we also built binary classifiers with raw
dMRI values as the input. We chose logistic regression with ridge reg-
ularization (McIlhagga, 2016) as the binary classifier of choice, thus
enforcing sparse and stable classification solutions. Explicitly, we
examined the following measures as inputs to the classifier:
(1) FA/FAt/FW raw values in each ROI separately, (2) FA/FAt/FW z-
score values in each ROI separately, (3) FA/FAt/FW z-scores in all
ROIs simultaneously (concatenated into one vector of length 18 for
each dMRI measure), (4) FAt and FW z-scores in all ROIs simulta-
neously (concatenated into one vector of length 36 for each subject),
and (5) combination of summary measures and the aforementioned
inputs.
Prediction performance of the estimated models was validated
using a 10-fold cross-validation procedure. The data were par-
titioned into 10 subsets—seven subsets comprised of 51 subjects
from the control group and 60 subjects from the schizophrenia
group, two subsets comprised of 52 subjects from the control group
and 60 subjects from the schizophrenia group, and one subset com-
prised of 51 subjects from the control group and 61 subjects from
the schizophrenia group. In each cross-validation round, one of the
10 subsets served as the test set, while the other 9 subsets served
as the training set for the binary classifier. The average of the area
under the receiver operator curve (AUC), across the 10 test sets,
was the evaluation metric. We note that in each cross-validation, the
normative range, as well as the choice of a bandwidth, were esti-
mated using only the healthy control subjects that belonged to the
corresponding training set. This guaranteed that the classification
performance on the test sets was not biased by the estimated nor-
mative model.
In order to examine whether sex differences exist, we have
repeated the same process (including the choice of a bandwidth) for
males and females separately.
Algorithm 1
Calculation of FA z-scores for every subject
// Calculate bandwidth and weight function for each ROI
for each ROI R do:
h[R] minimizer of cross-validation function (Equation (2)) calculated using FA values of control group in ROI R
// Calculate z scores for subjects diagnosed with schizophrenia
for each “subject diagnosed with schizophrenia” s do:
age_s age of subject s
sex_s sex of subject s
for each ROI R do:
FA[1,…,n] FA values in ROI R of all controls of sex_s
age[1,…,n] ages of all controls of sex sex_s
// Calculate mean and standard deviation in controls centered at age_s
FA_s FA value in ROI R of subject s
Mean weighted_mean(FA,FA_s,age,age_s,h[R]) using Equation (1a)
Std weighted_std(FA,FA_s,age,age_s,h[R]) using Equation (1b)
// Calculate z-score for subject s
Z_scz[s] FA_sMeanStd
// Calculate z scores for control subjects
for each control subject c do:
age_c age of subject c
sex_c sex of subject c
for each ROI R do:
FA[1,…,m] FA values in ROI R of all controls of sex sex_c excluding control c
age[1,…,m] ages of controls of sex sex_c excluding control c
FA_c FA value in ROI R of control c
Mean weighted_mean(FA,FA_s,age,age_s,h[R]) using Equation (1a)
Std weighted_std(FA,FA_s,age,age_s,h[R]) using Equation (1b)
Z_HC[c] FA_cMeanStd
return (Z_scz,Z_HC)
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3 | RESULTS
3.1 | Group-level differences in ROI-wise values
Group comparisons of the raw FA values of the 18 ROIs between the
healthy controls group and the schizophrenia group identified signifi-
cantly lower FA values in the schizophrenia group in 12/18 ROIs
(Figure 2 and Table S2), which is consistent with previous case–control
studies in schizophrenia (Kelly et al., 2018; Lv et al., 2020; Wolfers
et al., 2018 and the references therein) and studies using the same
dataset as ours (Cetin-Karayumak et al., 2020). Group comparisons
between the z-scores of the FA values identified significant differences
in 14/18 ROIs. Of note, the effect sizes for group-differences were
higher (p < .001 using a one-sided paired t test; Cohen's d = 0.294)
when testing for differences in z-scores, compared with testing for dif-
ferences in the raw FA values (Figure 2 and Figure S1).
3.2 | Subject specific z-score derived summary
measures
The ROI with the highest occurrence of infra-normal z-values
(z < 2.9913) was the Forceps major (Fmajor), found in only 19/601
(3.16%) individuals diagnosed with schizophrenia (Table S3). In addi-
tion, 62/601 (10.3%) of the individuals diagnosed with schizophrenia
had at least one infra-normal ROI, compared to 37/512 (7.2%) of the
healthy controls.
All z-score derived distribution summary measures showed a sig-
nificant group-difference with varying effect sizes (Figure 3). These
measures included load (p = .039; Cliff's delta = 0.03), severity
(p = .015; Cliff's delta = 0.075), average z-score across all ROIs
(p < .001; Cliff's delta = 0.213), and standard deviation of z-score
values (p = .002; Cliff's delta = 0.098).
Testing what range of FA z-scores best discriminates the schizo-
phrenia group from the control group identified the range of
3.36 < z < 0.6, corresponding to lower FA values in the schizo-
phrenia group. This range only partially overlaps with the infra-normal
range of z < 2.99. In addition, the majority of the values within this
range are well within what is considered the “normal” range
(jzj < 2.99). Identifying the fraction of fiber tracts with values in the
significant range had higher effect size than using any of the other
summary measures (fraction in significant range, p << .001; Cliff's
delta = 0.2369). However, we note that effect sizes for the sum-
mary measures were smaller than those for the group differences of
the average z-score in individual tracts (e.g., Fmajor p < .001; Cliff's
delta =0.25), see Figure 3.
F IGURE 3 Summary measures. The
plots present effect sizes (in absolute
values) for group differences in each of
the summary measures. For comparison,
the effect size obtained when using only
the value for the Forceps major is
included. sign = significant,
std = standard deviation,
Fmajor = Forceps Major. Error bars
represent 95% confidence interval for
Cliff's-delta effect size (Feng &
Cliff, 2009). Group difference p-values: ★
.01 < p < .05, ★★ .001 < p < .01,
★★★ p < .001
F IGURE 2 Group differences in raw
and z-score FA values. The plots display
effect sizes obtained when testing for
lower raw FA values in the schizophrenia
group (orange bars) or lower FA z-scores
(blue bars). Most ROIs showed significant
group differences in both raw and z-score
values, although the effect sizes for the z-
scores were higher than for the raw
values. The full ROI names are detailed in
supplementary material. Error bars
represent 95% confidence interval for
Cohen's-d effect size. Group difference p-
values:★ .01 < p < .05, ★★
.001 < p < .01, ★★★ p < .001
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3.3 | Prediction models
The use of the raw FA value or the z-score value for each ROI individ-
ually as input for a prediction classifier, resulted in relatively low pre-
dictive performance (Figure 4). In the majority of tracts (15/18), the
mean AUC (averaged across the cross validations) obtained for the z-
score values as input to the classifier was higher than the mean AUC
for the raw values as input. Of these, the best predictors were the z-
scores of the WM skeleton average (AUC = 0.64), followed by the
Forceps Major (Fmajor, AUC = 0.627), Fornix (AUC = 0.627), and
the Forceps Minor (Fminor, AUC = 0.621) ROIs. Importantly, using
the z-scores of all ROIs simultaneously as input to the binary classifier
resulted in a higher predictive power than any individual ROI
(Figure 4), yielding an AUC of 0.67. Inclusion of the subject specific
summary measures to the z-scores in all the other ROIs did not
improve the AUC.
3.4 | Multiple imaging features
Upon repeating the analyses for the FAt and FW measures derived
from free-water imaging (Table S2), we found that the number of indi-
viduals diagnosed with schizophrenia who had infra-normal FAt or
supra-normal FW values was higher than the number of individuals
diagnosed with schizophrenia who had infra-normal FA. At the same
time, the number of healthy controls with abnormal FAt or FW did
not increase compared to our FA analyses (Table S3). Specifically,
87/601 (14.47%) of the individuals diagnosed with schizophrenia had
at least one ROI with an infra-normal FAt value, compared to 38/512
(7.42%) of the healthy controls. Similarly, 84/601 (13.97%) of the indi-
viduals diagnosed with schizophrenia had at least one ROI with a
supra-normal FW value, compared to 35/512 (6.8%) of the healthy
controls. Similar to FA, regions in the z-distributions which exhibited
F IGURE 4 Prediction power for
individual ROIs and ROIs combined.
Prediction power is reported as area
under the receiver–operator curve (AUC),
averaged over the cross-validations in
each ROI. AUC is reported for z-scores
(blue bars) and for raw values (orange
bars). The full ROI names are detailed in
supplementary material
F IGURE 5 Strongest
predictors per dMRI modality.
Each ROI is colored according to
the dMRI modality (FA in green,
FAt in red, and FW in blue) that
had the highest AUC for
classification
F IGURE 6 Prediction power for dMRI modalities. Area under the
receiver–operator curves (AUC), averaged over the cross-validations,
obtained when inputting the values in all ROIs simultaneously into the
classifier, for FA (green bars), FAt (red bars), FW (blue bars) and FAt
+FW (orange bars)
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group differences extended within what is considered the “normal”
range, exhibiting lower FAt values (4.3 < z < 0.6) and higher FW
values (0.97 < z < 3.08) in the schizophrenia group compared to the
healthy control group.
Compared with the FA analyses, the individual ROI analyses had
higher AUC scores in either FAt or FW: FAt had the highest AUC in
8/18 ROIs, FW in 5/18 ROIs and FA in 5/18 ROIs (Figure 5). Addi-
tionally, when inputting the z-scores of all the fiber tracts simulta-
neously into the binary classifier, both FAt and FW had higher AUC
than FA, reaching an AUC of 0.68 and 0.7, respectively (Figure 6 and
Figure S2). The highest score (AUC = 0.726) was achieved when
inputting together all the z-scores of all ROIs for both the FAt and the
FW measures into the classifier (Figure 6). We note that the largest
regression coefficients (averaged across cross-validations) were
assigned to FW across the WM skeleton, FAt across the WM skeleton
and FW in Fmajor (see also Figure S3).
When repeating the analysis for males and females separately, we
observe that in males, the complete distribution of z-scores in FAt
achieved higher score (AUC = 0.6958) than the complete distribution
of z-scores in FW (AUC = 0.6641), whereas the opposite was
observed in females (AUC = 0.6611 in FAt, AUC = 0.771 in FW), see
Figure S4. We also observe that in males, prediction using the z-scores
in all ROIs for both FAt and FW as input resulted in better perfor-
mance (AUC = 0.71) than predictions using the individual dMRI mea-
sures (AUC when using FAt = 0.69, AUC when using FW = 0.66),
whereas in females, prediction using both FAt and FW resulted in
comparable performance (AUC = 0.77) to the performance obtained
when only using FW (AUC = 0.77), but higher than the performance
obtained when using FAt (AUC = 0.66), see Figure S4. We also note
that while the largest regression coefficients in males were assigned
to FW across the WM skeleton ROI and FAt across the WM skeleton
ROI, the largest regression coefficients in females were assigned to
FW in Fmajor, FW in Fminor and FW across the WM skeleton ROI.
4 | DISCUSSION
In this article, we demonstrate the predictive potential of the norma-
tive modeling approach. Our key finding is that the use of the com-
plete distribution of deviations from the normative range of each
individual as an input to a binary classifier improves the predictive
performance for all tested measures (FA, FAt, FW). Even though we
only reached a performance level indicative of an “acceptable discrim-
ination” (c.f., p. 162 in Hosmer Jr, Lemeshow, & Sturdivant, 2013), our
findings can serve as an early step in the development of a classifica-
tion scheme that involves schizophrenia and therefore aid in subject-
level classification.
We also find that extreme deviations from the normative model
are not found in a sufficient number of individuals diagnosed with
schizophrenia, and, accordingly, summary measures based on extreme
deviations are less efficient diagnostic measures. Indeed, the z-
distribution analysis identified that the range of z-scores that best dis-
criminates the individuals diagnosed with schizophrenia from controls
is bounded and does not include the most extreme range of z-scores.
This strongly suggests that extreme z-scores may not be indicative of
schizophrenia related pathologies, but rather of other effects such as
noise, imaging artifacts, or medication effects (Meng et al., 2019).
Instead of focusing on summary measures of extreme z-scores,
we find that the complete distribution of deviations, and their com-
bined effect on a number of imaging measures provides a more solid
basis for prediction algorithms, also suggesting that underlying pathol-
ogies in schizophrenia are likely subtle and diverse. We emphasize
that since our evaluation metric (AUC) is computed on the different
test sets, rather than on the training sets, it is not a priori expected
that the inclusion of more features will necessarily result in an
improved prediction (Guyon & Elisseeff, 2003). In particular, adding
features that are irrelevant (e.g., random noise) or redundant
(e.g., correlated with one of the already present features) is not
expected to improve the predictive performance and may worsen the
model generalizability by increased overfit (Guyon & Elisseeff, 2003;
Veronese, Castellani, Peruzzo, Bellani, & Brambilla, 2013; Ying, 2019).
The finding of an improved predictive performance when using the
complete deviation distribution across multiple white matter ROIs
therefore highlights the non-localized nature of white matter abnor-
malities in schizophrenia.
Similar to our findings, three previous studies that applied norma-
tive modeling on schizophrenia datasets (Lv et al., 2020; Wolfers
et al., 2018, 2021) also found that considering each ROI separately
identifies only a small fraction of subjects as abnormal. These results
suggest biological heterogeneity in the location of abnormalities
across different subjects. Our results, however, further suggest that
location heterogeneity is not the only factor underlying abnormalities
across the schizophrenia group, but rather that the interplay between
individual deviations across different brain location is also involved.
This finding coincides with previous studies that highlight the impor-
tance of the relationship between different fiber tracts involved with
schizophrenia (Gheiratmand et al., 2017; Klauser et al., 2017). More-
over, compared with the previous normative modeling studies, we
find a smaller fraction of subjects with at least one “abnormal” ROI.
This can be attributed to differences in the dataset sizes, normative
range models, confounders control schemes, and abnormality thresh-
old, affecting the quality of prediction. We note, however, that the
previous studies did not investigate the potential use of the individual
deviation measures in the context of subject-level predictions. These
studies also did not compare the performance of individual deviation
maps with raw values in the context of group-differences and did not
consider inclusion of multiple dMRI measures into their analysis.
It is further instructive to examine our manuscript in light of three
criteria suggested in Marquand et al. (2019) for the categorization of
different normative modeling approaches. The first criterion is the
choice of covariates and response variables. In our approach, age is
the only covariate, while the response variable is one of several diffu-
sion MRI measures in each white matter ROI. Even though sex is not
treated as an additional covariate, it is explicitly accounted for by esti-
mating sex-specific normative models. The second criterion is based
on the chosen way to separate different sources of variation, and in
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particular to differentiate between variation across participants from
variation due to parameter and model uncertainty. In light of this cri-
terion, our normative model is effectively nonlinear and nonparamet-
ric, and controls for the degree of uncertainty by the choice of a
bandwidth that minimizes the leave-one-out cross-validation error.
This is comparable with previous nonparametric approaches for age-
adjustment. The third criterion suggested in Marquand et al. (2019) is
the degree of individual prediction provided by the normative model.
This criterion deals with the ability of the normative model to perform
single-subject inferences. In contrast to normative modeling
approaches that only provide numerical deviations from the normative
model (Cole & Franke, 2017; Marquand et al., 2019). Our model also
accounts for the variance within the healthy control group, when pro-
viding individual inferences, and therefore allows to estimate the sta-
tistical significance of each individual deviation from the normative
range. We also compute several participant-level summary statistics
to estimate overall deviation from the normative pattern.
By applying the free-water model, we demonstrated that the
dMRI signal holds more information regarding schizophrenia patholo-
gies than the FA measure. Both the FAt and FW measures had overall
better predictive power than the FA measure alone, suggesting that
the increased specificity provided by the more elaborated free-water
model is able to identify features that are more directly contributing
to the separation between individuals diagnosed with schizophrenia
and healthy controls. Additionally, including both FAt and FW
together had the best predictive power. The improvement in predic-
tive power compared to each measure on its own, suggests that
accounting for the co-occurrence of two or more pathologies is also
important for the characterization of schizophrenia. This is in line with
previous free-water studies that identified variable rates of FAt and
FW abnormalities along the different stages of schizophrenia (Lyall
et al., 2018; Oestreich et al., 2017; Pasternak et al., 2015; Pasternak,
Westin, et al., 2012; Tang et al., 2019), further supporting the hypoth-
esis that each measure accounts for a different pathology. Finally, the
application of the free-water model resulted in differences between
males and females with respect to the best predictors. This is aligned
with previous studies which observed sexually-dimorphic free water
increase, which was suggested to be the result of an increased acute
response in the female subjects diagnosed with schizophrenia relative
to male subjects (Lyall et al., 2018). We note, however, that even
though these findings may suggest different abnormality patterns
between the sexes, they might as well be the result of differences in
the number of subjects of each sex (659 males, 454 females) in our
data, or due to the different proportions of subjects belonging to the
control group versus subjects belonging to the schizophrenia group
(279:380 in males, 233:221 in females), and therefore requires further
research.
We note that previous studies showed that the type and extent
of FAt and FW abnormalities depend on age, and on the stage of the
disorder (e.g., prodromal, first-psychotic episode, early psychosis, and
chronic) (Pasternak, Kelly, Sydnor, & Shenton, 2018). Therefore, the
current data, that are heterogeneous in terms of disorder stage, may
not be optimal for the identification of predictive clinical features.
Nevertheless, the acceptable level of predictive power is expected to
increase when the same methods are applied to datasets that are clini-
cally more homogenous.
Our findings show that the combination of multiple imaging fea-
tures increases the predictive performance of the model. This sug-
gests that it would be beneficial to include additional measures of
interest, for example, more elaborate dMRI models, clinical pheno-
types, or volumetric/cortical thickness measures, and develop more
elaborate normative models that combine information from more than
one feature at a time, to further improve prediction performance. , In
this study we focused on the prediction of single-subject classification
(i.e., schizophrenia or control) where we used regularized ridge regres-
sion. The choice of this binary classifier, together with the relatively
large sample size, considerably reduced the risk of overfitting
(Arbabshirani et al., 2017). However, the use of more elaborate
machine-learning models (Ardekani et al., 2011; Chand et al., 2020;
Lee et al., 2018; Mikolas et al., 2018; Srinivasagopalan, Barry,
Gurupur, & Thankachan, 2019) could also be considered in order to
increase further the predictive performance. Availability of clinical
parameters may also generalize our approaches to the prediction of
other properties, such as clinical outcome, or treatment response. We
anticipate that using normative models will improve performance of
such prediction models as well.
An additional contribution of this article is our novel approach to
controlling for confounders, namely, age and sex. Our approach mainly
differs from recent studies using normative modeling (Bouix et al., 2013;
Chamberland et al., 2020; Dean III et al., 2017; Dimitrova et al., 2020; Lv
et al., 2020; Marquand et al., 2016; Pasternak et al., 2014; Taylor
et al., 2020; Wolfers et al., 2018) by our consideration of sex in an exact-
matching way, rather than as an additional covariate. Our approach for
controlling for age is similar to other studies using nonparametric
methods for the modeling of the normative range, see for example,
(Marquand et al., 2019) for a review. Most common methods for
adjusting for age and sex assume the dependency has a functional form,
for example, linear, which may be either an over-simplification or over-
fitting, depending on the complexity of the functional form. In turn, mis-
modeling the dependency of age and sex could result in bias or noise
that could cause false positive and false negative findings. Our method is
nonparametric, and, similar to Wolfers et al. (2018), is therefore not only
robust but it does not rely on any assumptions on the functional form.
The use of a leave-one-out approach for choosing the bandwidth also
allows for better control of the confounding variables, and makes it pos-
sible to identify ROIs that do not necessarily need to be adjusted. While
in the ideal situation of infinitely many healthy controls, the best way to
control for age and sex would be to model the normative range for every
subject by only considering healthy controls that exactly match the
subject's covariates—Our method builds on the idea of exact matching
but is also suitable for finite sample sizes, where an infinite size of
healthy control population is not available. We note that the fact that
the individual deviations provided better effect sizes and predictive
power than the raw values could also be attributed to the inherently
more accurate control for age/sex that was applied in the calculation of
the deviations.
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This study nonetheless has several limitations. First, since the
dMRI data from this study were retrospectively harmonized, they
were not acquired with state-of-the-art acquisition protocols. A more
current protocol with multiple b-value shells and better image resolu-
tion would improve the accuracy of the bi-tensor model fit (Pasternak,
Shenton, & Westin, 2012). Second, the analysis we performed did not
account for the data heterogeneity in the context of different treat-
ment protocols and different comorbid substance use/abuse, which
may serve as possible confounders of our results. In addition, as previ-
ous studies (Hill et al., 2013; Reininghaus et al., 2019; Skudlarski
et al., 2013; Tamminga et al., 2013) show that the abnormality pattern
observed in schizophrenia overlaps with the abnormality pattern
observed in other psychotic disorders, it is a matter of future research
to test the specificity of our findings to schizophrenia. Lastly, investigat-
ing the relationship between clinical symptoms and the brain abnormali-
ties found is beyond the scope of the current article, but serves as an
important avenue for future studies.
In conclusion, our findings suggest several important insights to
subject-level classification methods and their utility in schizophrenia.
First, normative modeling approaches may improve subject-level pre-
dictions. Second, setting a “normal” threshold and using only those
deviations that exceed this threshold derives summary measures that
are limited in their ability to perform predictions. Rather, the interplay
between the individual deviations across different fiber tracts is pre-
ferred. Third, splitting FA values into FAt and FW contributions may
improve the group separation of healthy controls and schizophrenia.
Taken together these conclusions imply that schizophrenia is highly
likely to be characterized by subtle changes in white matter micro-
structure that are distributed across brain locations, rather than char-
acterized by severe focal lesions.
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